Detalhe da pesquisa
1.
EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma.
Ann Oncol
; 34(11): 1047-1054, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37678672
2.
Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up.
Ann Oncol
; 34(3): 289-299, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36494006
3.
Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials.
Ann Oncol
; 31(4): 525-531, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32115349
4.
Cytoreductive nephrectomy in metastatic renal cell carcinoma: outcome of patients treated with a multidisciplinary, algorithm-driven approach.
World J Urol
; 38(12): 3199-3205, 2020 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-32128610
5.
Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ann Oncol
; 2024 May 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38788900
6.
ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma.
Ann Oncol
; 35(6): 485-490, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38490358
7.
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees.
Ann Oncol
; 30(11): 1697-1727, 2019 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31740927
8.
Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).
Ann Oncol
; 29(2): 361-369, 2018 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29077785
9.
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up.
Ann Oncol
; 29(8): 1658-1686, 2018 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30113631
10.
Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ann Oncol
; 33(4): 362-375, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35065204
11.
Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ann Oncol
; 33(3): 244-258, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34861372
12.
Recent eUpdate to the ESMO Clinical Practice Guidelines on renal cell carcinoma on cabozantinib and nivolumab for first-line clear cell renal cancer: Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol
; 32(3): 422-423, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33271289
13.
ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma.
Ann Oncol
; 32(12): 1511-1519, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34597799
14.
A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK).
Ann Oncol
; 27(5): 880-6, 2016 05.
Artigo
Inglês
| MEDLINE | ID: mdl-26802156
15.
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.
Ann Oncol
; 27(3): 379-90, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26681681
16.
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project.
Ann Oncol
; 26(12): 2392-8, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26371288
17.
Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma.
Br J Cancer
; 110(3): 616-24, 2014 Feb 04.
Artigo
Inglês
| MEDLINE | ID: mdl-24366299
18.
Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).
Ann Oncol
; 30(11): 1841, 2019 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31868903
19.
Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended follow-up from the phase III randomised CheckMate 9ER trial.
ESMO Open
; 9(5): 102994, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38642472
20.
A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancer.
Ann Oncol
; 24(8): 2098-103, 2013 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-23579815